ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
101 730,00
-0,67%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Caribou Biosciences Inc (CRBU) Cours

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1,43
0,12
(9,16%)
Fermé 01 Février 10:00PM
Retardé de 15 minutes
1,46
0,03
(2,10%)
Après les heures de négociation: 1:13AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,46
Prix Achat
1,45
Prix Vente
1,49
Volume échangé
3 596 538
1,32 Fourchette du Jour 1,57
1,30 Plage de 52 semaines 8,33
Cap du marché
132,207M
Clôture Veille
1,31
Ouverture
1,345
Dernière Transaction
3
@
1.49
Dernière heure de transaction
Volume financier
US$ 5 284 435
VWAP
1,4693
Volume moyen (3 m)
1 520 840
Actions en circulation
90 552 687
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,27
Bénéfice par action (BPA)
-1,13
Chiffre d'affairess
34,48M
Bénéfice net
-102,07M

À propos de Caribou Biosciences Inc

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.cariboubio.com
Siège social
Dover, Delaware, USA
Fondé
-
Caribou Biosciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CRBU. Le dernier cours de clôture d'Caribou Biosciences était de US$1,31. Au cours de la dernière année, les actions de Caribou Biosciences ont été négociées dans une fourchette de prix de US$ 1,30 à US$ 8,33.

Caribou Biosciences compte actuellement 90 552 687 actions en circulation. La capitalisation boursière d'Caribou Biosciences est de US$118,62 million. Caribou Biosciences a un ratio cours/bénéfice (ratio PE) de -1.27.

CRBU Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

30 Janvier 2025
Edgar (US Regulatory)

Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025...

30 Janvier 2025
PR Newswire (US)

The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline

The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Jan. 27, 2025 NEW YORK, Jan. 27, 2025...

27 Janvier 2025
PR Newswire (US)

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) Shareholders PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025...

23 Janvier 2025
PR Newswire (US)

Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBU

Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBU PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK , Jan. 20, 2025...

20 Janvier 2025
PR Newswire (US)

CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025...

16 Janvier 2025
PR Newswire (US)

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025...

13 Janvier 2025
PR Newswire (US)

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

-- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L...

13 Janvier 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.08-5.194805194811.541.551.315711441.3869134CS
4-0.215-12.83582089551.6752.041.315556451.56622184CS
12-1.36-48.22695035462.822.951.315208401.87655373CS
26-0.87-37.3390557942.332.99951.312576781.9721752CS
52-4.54-75.666666666768.331.316705243.02489427CS
156-9.17-86.265286923810.6313.191.313380765.1007561CS
260-16.19-91.728045325817.6532.6451.312345486.32364871CS

CRBU - Frequently Asked Questions (FAQ)

What is the current Caribou Biosciences share price?
The current share price of Caribou Biosciences is US$ 1,46
How many Caribou Biosciences shares are in issue?
Caribou Biosciences has 90 552 687 shares in issue
What is the market cap of Caribou Biosciences?
The market capitalisation of Caribou Biosciences is USD 118,62M
What is the 1 year trading range for Caribou Biosciences share price?
Caribou Biosciences has traded in the range of US$ 1,30 to US$ 8,33 during the past year
What is the PE ratio of Caribou Biosciences?
The price to earnings ratio of Caribou Biosciences is -1,27
What is the cash to sales ratio of Caribou Biosciences?
The cash to sales ratio of Caribou Biosciences is 3,76
What is the reporting currency for Caribou Biosciences?
Caribou Biosciences reports financial results in USD
What is the latest annual turnover for Caribou Biosciences?
The latest annual turnover of Caribou Biosciences is USD 34,48M
What is the latest annual profit for Caribou Biosciences?
The latest annual profit of Caribou Biosciences is USD -102,07M
What is the registered address of Caribou Biosciences?
The registered address for Caribou Biosciences is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Caribou Biosciences website address?
The website address for Caribou Biosciences is www.cariboubio.com
Which industry sector does Caribou Biosciences operate in?
Caribou Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces